Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Finerenone was beneficial in primary and secondary prevention across the spectrum of patients with ...

The results may "reflect the fact that once a patient had an ASCVD event, they are subsequently well treated with secondary prevention medications such as antiplatelet agents and lipid-lowering ...

Per the 2018 American Heart Association/American College of Cardiology Multisociety Guideline for the Management of Blood Cholesterol (2018 AHA/ACC Guideline), [1] the cardiologist should discuss the ...

Higher levels of lipoprotein(a) (Lp[a]) were found to be associated with a continuously increasing risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events. A new analysis of the Family ...

Lipoprotein(a) appears to be an egalitarian risk factor, with high levels tied to an increased risk of atherosclerotic cardiovascular disease (ASCVD) in a wide range of primary-prevention patients, ...

—Recent studies suggest that a hospitalization related to cardiovascular events can follow a hospitalization for chronic obstructive pulmonary disease. But have these studies been too broad? No ...

Please provide your email address to receive an email when new articles are posted on . Premature menopause was associated with an increased risk for atherosclerotic CVD, according to new findings ...

A woman’s pregnancy history—specifically, the overlap among number of pregnancies and number of complications—at age 40 predicts her risk of dying from atherosclerotic cardiovascular disease (ASCVD) ...

The AHA/ACC published a new clinical practice guideline on managing cholesterol and provided a risk assessment report on primary prevention of ASCVD. The American Heart Association (AHA) and the ...